In prostate cancer cells, integrin αvβ3 carried by TDEs plays a clear role in inducing the differentiation of receptor cells into neuroendocrine PrCa (NEPrCa) cells; this cell subtype expresses neuron-specific proteins and can activate -tumour-promoting pathways independent of androgen receptor (AR) action [96]. Here, AR is linked to prostate carcinoma.